Materials and Method
For allpatients treated with PBTat our centre, the baseline
characteristics, imaging features, pathology including molecular
information, multimodality treatment, proton therapy technique, plan
parameters, quality assurance metrics, set-up and delivery parameters,
treatment response and their subsequent follow-up information are being
routinely captured in a prospectively maintained registry. The present
work focusses on reporting baseline characteristics, diagnosis,
treatment delivery parameters, treatment related acute toxicity and
follow-up information of all children and young adults <25
years of age consecutively treatedpatients treated at our centre.